A peculiar role for oxidative stress in non-alcoholic fatty liver disease (NAFLD) and its
transition to the inflammatory complication non-alcoholic steatohepatitis (NASH), as well as …

Non‐alcoholic fatty liver disease (NAFLD), recently re‐defined and re‐classified as
metabolic dysfunction‐associated fatty liver disease (MAFLD), has become increasingly …

The present study is the first effort to evaluate the effects of vitamin B12 supplementation on
the serum level of liver enzymes, homocysteine, grade of hepatic steatosis, and metabolic …

Non-alcoholic fatty liver disease (NAFLD) represents an increasing cause of liver disease
worldwide, mirroring the epidemics of obesity and metabolic syndrome. As there are still no …

The prevalence of non-alcoholic fatty liver disease (NAFLD), ranging from simple steatosis
to inflammatory steatohepatitis (NASH) and cirrhosis, continues to rise, making it one of the …

Peroxisome proliferator-activated receptor alpha (PPAR-a) is a crucial nuclear transcription
regulator of lipid metabolism, which is closely associated with the initiation and development …

Non-alcoholic fatty liver disease (NAFLD) has been associated with meat consumption in
cross-sectional studies. However, only a few prospective studies have been conducted, and …

Introduction Nonalcoholic steatohepatitis (NASH), also known as metabolic steatohepatitis,
is a clinical syndrome with pathological changes like alcoholic hepatitis but without a history …

In the current review, we focused on identifying aliment compounds and micronutrients, as
well as addressed promising bioactive nutrients that may interfere with NAFLD advance and …

Therapeutic approaches that lower circulating low-density lipoprotein (LDL)-cholesterol
significantly reduced the burden of cardiovascular disease over the last decades. However …